FindTrial
Sign In

To assess the overall effect of COVID-19 on intent of treatment and staging of cancer

A comparative analysis between annual audits to study the impact of COVID 19 on cancer diagnosis, stage of presentation and intent of treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028648
Enrollment
350
Registered
2020-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Aditi Chaturvedi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients should have undergone staging procedures using established clinical radiological or surgical methods All patients newly registered at the participating centre between 1.1.2019 to 31.12.2020 with a confirmed histopathological diagnosis of any malignancy

Exclusion criteria

Exclusion criteria: Patients who are registered before 1.1.2019 with a confirmed histopathological diagnosis of any malignancy. Patients registered at different centres.

Design outcomes

Primary

MeasureTime frame
To study the impact of the COVID 19 pandemic on the number of solid cancer patients presenting at a tertiary centre, the stage of presentation and the intent of treatment Timepoint: 12 months—

Secondary

MeasureTime frame
To assess the overall effect of COVID-19 on cancer patient treatment and severity.Timepoint: 24 months—

Countries

India

Contacts

Public ContactDr Aditi Chaturvedi

Max Super Speciality Hospital,A Unit of Devki Devi Foundation

aditi.chaturvedi28@gmail.com9869845680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026